Diagnostic Utility of Direct Immunofluorescence in Renal Biopsies with Diabetic Nephropathy

Abstract

Diabetic nephropathy (DN) is one of the leading causes of chronic kidney disease and end-stage renal disease worldwide, and renal biopsies performed in diabetic patients frequently reveal a broad and overlapping spectrum of glomerular pathology. Light microscopy remains the primary tool for renal biopsy interpretation, but direct immunofluorescence (DIF) provides an essential ancillary means of identifying immune deposits that are not always evident on routine histopathology, helping to differentiate DN from immune-mediated glomerular disease and to detect superimposed renal pathology. This observational study was conducted over 18 months on 42 adequately sampled native renal biopsies, each evaluated by light microscopy and DIF for IgG, IgA, IgM, C3, C1q, kappa and lambda light chains, and fibrinogen. The study population showed a male predominance (73.8%; male-to-female ratio 2.8:1) with a mean age of 42.1 years and peak incidence in the 51-60-year age group. IgA (95.2%), kappa (90.5%), and lambda (88.1%) were the most frequently positive markers overall, and C1q positivity (66.7%) exceeded C3 positivity (42.9%), suggesting frequent classical complement pathway activation. DN was the single most common diagnosis (33.3%), followed by lupus nephritis (11.9%), with membranous nephropathy, membranoproliferative glomerulonephritis, and nephrosclerosis accounting for 7.1% each. Biopsies with DN typically showed negative or weak, nonspecific staining, in clear contrast to the strong, granular “full-house” positivity of lupus nephritis and the granular capillary-wall IgG deposition of membranous nephropathy. These findings confirm that DIF has diagnostic, classificatory, and exclusionary value in the renal biopsy work-up of diabetic patients, and is particularly important for identifying superimposed immune-mediated glomerular disease that would otherwise be missed on light microscopy alone.

Keywords: diabetic nephropathy; direct immunofluorescence; renal biopsy; immunoglobulin deposition; glomerulonephritis